ChiCTR2400087846 版本V1.0 版本创建时间2024/08/05 19:22:44 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400087846 

最近更新日期:

Date of Last Refreshed on:

2024-08-05 19:22:10 

注册时间:

Date of Registration:

2024-08-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于下肢肌肉协同探讨温针灸配合太极拳干预膝骨关节炎疗效的运动控制机制

Public title:

Exploring the Motor Control Mechanism of Warm Needle and Taiji Improving Pain in Knee Osteoarthritis Based on Muscle Synergy for Human Lower Extremity

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于下肢肌肉协同探讨温针灸配合太极拳干预膝骨关节炎疗效的运动控制研究

Scientific title:

Exploring the Motor Control Mechanism of Warm Needle and Taiji Improving Pain in Knee Osteoarthritis Based on Muscle Synergy for Human Lower Extremity

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王晓玲 

研究负责人:

王晓玲 

Applicant:

Xiaoling Wang 

Study leader:

Xiaoling Wang 

申请注册联系人电话:

Applicant telephone:

+86 157 0596 0213

研究负责人电话:

Study leader's
telephone:

+86 157 0596 0213

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

535286728@qq.com

研究负责人电子邮件:

Study leader's E-mail:

535286728@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市闽侯县上街镇邱阳西路 1 号福建中医药大学

研究负责人通讯地址:

福建省福州市闽侯县上街镇邱阳西路 1 号福建中医药大学

Applicant address:

Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang West Road, Shangshang Town, Minhou County, Fuzhou City, Fujian Province

Study leader's address:

Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang West Road, Shangshang Town, Minhou County, Fuzhou City, Fujian Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福建中医药大学

Applicant's institution:

Fujian University of Traditional Chinese Medicine

研究负责人所在单位:

福建中医药大学

Affiliation of the Leader:

Fujian University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022-k1-040

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建中医药大学附属第三人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-08 00:00:00

伦理委员会联系人:

占璐

Contact Name of the ethic committee:

Zhan Lu

伦理委员会联系地址:

福建省福州市闽侯县上街镇国宾大道363号

Contact Address of the ethic committee:

No.363, Guobin Avenue, Shangjie Town, Minhou County, Fuzhou City, Fujian Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 139 5911 4795

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建中医药大学附属第三人民医院

Primary sponsor:

Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

福建省福州市闽侯县上街镇国宾大道363号

Primary sponsor's address:

No.363, Guobin Avenue, Shangjie Town, Minhou County, Fuzhou City, Fujian Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建中医药大学

具体地址:

福建省福州市闽侯县上街镇邱阳西路 1 号福建中医药大学

Institution
hospital:

Fujian University of Traditional Chinese Medicine

Address:

Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang West Road, Shangshang Town, Minhou County, Fuzhou City, Fujian Province

经费或物资来源:

中国康复医学会 2022 年度科技发展项目

Source(s) of funding:

China Rehabilitation Medical Association 2022 annual science and technology development project

研究疾病:

膝骨关节炎  

Target disease:

Knee Osteoarthritis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.明确 KOA 患者与健康人群的关节失稳特点和运动控制策略; 2.阐明温针灸配合太极拳干预 KOA 的临床疗效,建立标准化康复方案; 3.揭示温针灸配合太极拳干预 KOA 疗效的运动控制机制。  

Objectives of Study:

1. Clear joint instability characteristics of KOA patients and healthy people and motion control strategy; 2. To clarify the clinical efficacy of warm needle combined with Tai chi in the intervention of KOA, and establish a standardized rehabilitation program; 3. To reveal the motor control mechanism of the therapeutic effect of warm needle combined with Tai chi on KOA.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合以上诊断标准的 KOA 患者; 2.年龄 40-75 周岁; 3.签署知情同意书,愿意坚持整个治疗过程者; 4.治疗前 1 个月及治疗中均未服用激素类药物; 5.疼痛视觉模拟评分(VAS)≥3 分。

Inclusion criteria

1. KOA patients who met the above diagnostic criteria; 2. Age 40-75 years old; 3. Those who signed the informed consent and were willing to adhere to the whole treatment process; 4. In the treatment and 1 month before were not taking hormone drugs; 5. Visual analogue scale (VAS) score ≥3.

排除标准:

1.合并扭挫伤或其他外伤者; 2.X 线片显示关节间隙显著狭窄、大量骨赘形成或关节间形成骨桥连接而呈骨性强直者; 3.下肢关节严重畸形、红肿热痛较重者; 4.曾经进行过手术或关节镜治疗; 5.试验前 4 周接受过免疫抑制剂、肾上腺皮质激素局部或全身治疗者,妊娠期及哺乳期妇女。

Exclusion criteria:

1. Combined with contusion or other trauma; 2. X-ray films showed that the joint space was significantly narrow, a large number of osteophytes formed, or bone bridge formed between the joints. 3. Severe deformity of lower limb joint, redness, swelling and severe heat pain; 4. Ever had surgery or arthroscopic treatment; 5. Patients who had received local or systemic treatment with immunosuppressive agents and adrenocortical hormones 4 weeks before the trial, and pregnant or lactating women.

研究实施时间:

Study execute time:

From 2024-04-17 00:00:00 To 2025-05-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-09-12 00:00:00 To 2025-03-23 00:00:00

干预措施:

Interventions:

组别:

温针灸组

样本量:

20

Group:

Warm needle group

Sample size:

干预措施:

施行温针灸,留针约 30min。

干预措施代码:

Intervention:

Perform warm needle and leave the needle for about 30 minutes.

Intervention code:

组别:

太极拳组

样本量:

20

Group:

Tai chi group

Sample size:

干预措施:

太极拳教练带领 KOA 患者练习8个太极拳动作

干预措施代码:

Intervention:

The Tai chi instructor led the KOA patient to practice eight Tai chi movements

Intervention code:

组别:

温针灸配合太极拳组

样本量:

20

Group:

Warm needle combined with Tai chi group

Sample size:

干预措施:

实行温针灸+太极拳训练

干预措施代码:

Intervention:

Perform warm acupuncture + Tai Chi training

Intervention code:

组别:

健康人群

样本量:

20

Group:

Healthy people

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建中医药大学 

单位级别:

大学 

Institution
hospital:

Fujian University of Traditional Chinese Medicine

Level of the institution:

University

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建中医药大学附属第三人民医院 

单位级别:

三甲 

Institution
hospital:

The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

视觉模拟评分量表

指标类型:

主要指标

Outcome:

Visual analogue scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

KOOS 评分量表

指标类型:

次要指标

Outcome:

KOOS rating scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SF-36 量表

指标类型:

次要指标

Outcome:

SF - 36 scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医症状评分表

指标类型:

次要指标

Outcome:

TCM symptom rating scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 40 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由项目有关负责人将样本量和分组数输入计算机,产生随机种子数和分组数,制备随机卡,装于不透光信封密封后备用。将符合病例选择标准的受试对象按进入临床的先后顺序,对应随机卡信封的序号,拆开信封,按信封内的分组方案实施临床治疗。

Randomization Procedure (please state who generates the random number sequence and by what method):

By the project responsible person to sample size and the number of clusters input computer, generate random number seed and the number of clusters, the preparation of random card, reserve in opaque envelope seal. Would be consistent with the test subjects for the selection of cases according to the order into clinical, corresponding to the number of random card envelope opened the envelope and clinical treatment according to the grouping scheme of implementation in the envelope.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

本研究采用评估者和统计者盲法,采用二级设盲。一级盲底为受试者组别,用A、B、C表示二级盲底为受试者干预方式,用a、b、c表示。由不参与研究的研究人员保管盲底。研究结束后,将数据录入数据库,核对无误后进行一级揭盲。完成数据分析后,进行二级揭盲。

Blinding:

In this study, the blind method of evaluator and statistician was adopted. The primary blind base is the group of subjects, and the secondary blind base is the intervention mode of subjects, and the secondary blind base is represented by A, B, and C. The blind bottom is kept by researchers not involved in the study. After the end of the study, the data were entered into the database, and the first level of blinding was performed after verification. After the data analysis was completed, the secondary blinding was performed.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表和电子采集

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF and Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-08-05 19:22:10